Pharmicell signs ~7 billion won electronic materials supply contract with Doosan Electro Materials… short-term earnings boost expected


  • Pharmicell signed an electronic materials supply contract with Doosan Electro Materials (China) worth approximately 7 billion won (USD 4.62 million), representing 6.13% of 2025 revenue.
  • The contract period is short-term, from May 26, 2026 to July 31, 2026 (about 2 months), with payment terms of TT 60 days after B/L date.
  • While the contract is positive for securing stable sales in the short term, its size relative to total revenue is modest and the short duration limits the impact on stock price.
  • [AI Comprehensive Analysis]This contract may contribute to a one-time short-term revenue increase, but it is unlikely to provide significant stock momentum due to uncertainty in sustained orders. Investors should monitor additional order wins and earnings improvement pace.

KOSPI Filing Information


  • Filing: Conclusion of a Single Sales and Supply Contract
  • Company: Pharmicell (005690)
  • Submission: Pharmicell Co., Ltd.
  • Receipt: 05-27-2026
  • Under KRX KOSPI Market Division